US adviser on board of firm that sold anthrax drug

Associated Press SHARE

WASHINGTON (AP) — A report says former Navy Secretary Richard J. Danzig, who serves as a bio-warfare adviser to the president and Pentagon, urged the government to stockpile an anti-anthrax drug while serving as a director for the company that supplies it.

An investigation published Sunday by the Los Angeles Times (http://lat.ms/12K6Rxh) says Danzig warned terrorists could engineer a form of anthrax resistant to common antibiotics. It says Danzig successfully suggested stockpiling a drug known as "raxi" to guard against it.

At the same time he was among the directors at Human Genome Sciences Inc., which makes the drug, and he earned more than $1 million in company compensation between 2001 and 2012.

Danzig says he believes there's no conflict of interest, and that he sought only to keep the government informed.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.